Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

ImmuPharma (LSE: IMM) Breaks Higher: Is This Biotech Stock Back on Investors' Radar?

ImmuPharma plc (LSE: IMM) advanced 12.50% to 4.5p after a tangible development milestone for its diabetes programme. On 22 July 2026, the company selected Thermo Fisher Scientific's Patheon services as drug-product contract development and manufacturing organisation for Kapiglucagon. The appointment followed the earlier selection …

Ankur Sharma | 27 July 2026

Tristel (LSE: TSTL) Jumps Sharply: Is This Healthcare Growth Story Gaining New Momentum?

Tristel plc (LSE: TSTL) jumped 14.65% to 450p after issuing a positive trading update for the year ended 30 June 2026. The catalyst was straightforward: management expects revenue of about £51.1 million, 10% above the prior year, and adjusted profit before tax of at …

Ankur Sharma | 27 July 2026

AOTI (LSE: AOTI) Shares Skyrocket: Is This Healthcare Stock Entering the Spotlight?

AOTI, Inc. (LSE: AOTI) rose 32.58% to 87.5p after US Medicare administrative contractors issued a proposed nationwide Local Coverage Determination for topical oxygen therapy in eligible diabetic foot ulcers. The development is directly relevant to AOTI's TWO2 system and could widen reimbursement. It is …

Ankur Sharma | 27 July 2026

ImmuPharma plc (LSE:IMM) Extends Bullish Momentum as Development Pipeline Progress Strengthens Investor Optimism

ImmuPharma plc is a UK-based biotechnology company focused on developing novel therapeutics for autoimmune diseases, metabolic disorders and other areas of unmet medical need. The company's shares moved higher as investors responded positively to recent operational developments, growing confidence in its development programmes and …

Ankur Sharma | 24 July 2026

AOTI, Inc. (LSE:AOTI) Surges Higher as Transformational Update Fuels Investor Optimism and Positive Momentum

AOTI, Inc. is a medical technology company specializing in advanced wound-care solutions designed to improve outcomes for patients suffering from chronic and difficult-to-heal wounds. Its proprietary therapy platform has established a differentiated position within the wound management market by combining innovative treatment technology with …

Ankur Sharma | 24 July 2026

Oxford BioDynamics Share Price Declines as Investors Assess Commercial Growth Outlook

LSE:OBD – Oxford BioDynamics Plccame under heavy selling pressure after its shares fell12.00%during trading on24 July 2026.

Ankur Sharma | 24 July 2026

Proteome Sciences Stock in Focus After Heavy Decline as Healthcare Investors Reassess Growth

LSE:PRM – Proteome Sciences plcattracted significant market attention after its shares fell15.79%during trading on24 July 2026.

Ankur Sharma | 24 July 2026

Provexis Share Price Slides as Investors Reassess Functional Nutrition Growth Outlook

LSE:PXS – Provexis PLCattracted investor attention after its shares declined10.00%during trading on24 July 2026.

Ankur Sharma | 24 July 2026

Why Is Renalytix Among Today's Top UK Healthcare Gainers? Latest Growth Drivers Explained

Renalytix Plc gained5.66%on24 July 2026as investors continued favouring healthcare technology companies developing advanced diagnostic solutions supported by artificial intelligence and precision medicine.

Ankur Sharma | 24 July 2026

LSE:APTA Jumps More Than 8%: Why Healthcare Investors Are Watching Aptamer Group plc

• Aptamer Group plc (LSE:APTA) advanced approximately8.11%on24 July 2026, ranking among the strongest-performing UK healthcare stocks.

Ankur Sharma | 24 July 2026
Support

Hi! How can we help you today?

Loading…